PCV85 CLINICAL OUTCOME AND COST-EFFECTIVENESS OF DIFFERENT BYPASS MATERIALS IN VASCULAR SURGERY  by Eidt, D et al.
A114 Abstracts
horizon of the trial. Sensitivity analysis suggested that the results
were most sensitive to the cost of an angiography, the utility
values estimated, and the price of cilostazol. CONCLUSIONS:
Cilostazol is expected to be a cost-effective treatment for inter-
mittent claudication patients in Scotland.
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OBJECTIVE: Reduced hospital stay and intensive care unit stay
after endovascular aneurysm repair (EVAR) compared to open
repair (OR) of abdominal aortic aneurysms (AAA) are expected
to result in reduced costs of AAA repair. The cost and cost effec-
tiveness of OR and EVAR in the ﬁrst postoperative year were
compared in a randomised trial. METHODS: In a multicenter
randomised trial comparing OR and EVAR we randomly
assigned 149 patients to OR and 151 to EVAR. Complications,
costs and cost-effectiveness were determined one year after
surgery. The uncertainty surrounding the cost-effectiveness ratios
(iCER) was addressed by bootstrapping. RESULTS: Ten patients
had died in the OR group and 9 in the EVAR group (chi-square
p = 0.8). In the OR group, 32 patients had one or more severe
complications and in the EVAR group, 27 patients (chi-square p
= 0.5). EVAR was associated with €4.480 additional direct costs
per patient (€18.138 versus €13.659) and a decrease in QALY 
of 0.72 as compared with 0.73 (difference 0.01 year, 95% CI 
-0.04–0.06). With regard to event free survival over 85% of the
bootstrap estimates EVAR indicated favourable health outcomes
for EVAR, but against prohibitively higher costs. From a health
economic perspective OR is preferred. CONCLUSION: In
patients suitable for both treatments, EVAR is not cost-effective
in the ﬁrst postoperative year.
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OBJECTIVES: Open Surgery (OS) of abdominal aortic
aneurysms (AAAs) is a major surgical procedure with elevated
morbidity and a low but deﬁnite mortality. Endovascular repair
(EVAR) has now emerged as a minimally alternative to OS, and
its effectiveness has now been reported in the literature with
reduced peri-operative mortality and complication rates. The
aim of this study was to compare the full cost of the two treat-
ments. METHODS: A prospective, observational study was con-
ducted in a Vascular-Surgery Division from October 2003 to
April 2004. Data for patients undergoing treatment of an AAA
were collected. Cost assessment was carried out from the hospi-
tal perspective according to the Activity Based Costing princi-
ples. RESULTS: Data for 44 patients were gathered: 73%
underwent OS and 27% EVAR. The mean age was 66.7 (±16.7)
years and 7% of the patients were female. Comorbidity rates
were similar in the two treatments group. There was no differ-
ence in mean hospital length of stay (LOS) between the two
options (ten days). Mean post-operative LOS was 6.5 days (±4),
with signiﬁcant difference between the two groups (OS 7.5 ± 4
vs. EVAR 3.5 ± 0.6, p < 0.0001). Intensive therapy was neces-
sary only for OS patients (28%). The study revealed that the
overall mean cost to treat an AAA, irrespective of the technique
used, was €11,578.34 (€11,063.31 OS vs. 12,971.56 EVAR). A
sub-analysis was performed for complicated patients alone and
the mean cost was €13,487.46, with a difference between the
two treatments tending almost to zero. The use of post-
operative resources differed between the two treatments, result-
ing in differences for the mean post-operative costs (€5,686.07
for OR vs. €2,185.49 for EVAR). CONCLUSIONS: Stent graft
treatment of AAAs has been shown to be effective in reducing
the amount of nursing assistance, LOS and the need for inten-
sive therapy at the post-operative stage.
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OBJECTIVES: Bypass surgeries to circumvent occluded arteries
are common procedures not only in cardiac surgery but also for
occlusions in lower extremities or thorax. Different materials for
the bypass procedures are available: venous, arterial and syn-
thetic; each with different properties, advantages and costs. The
objective is to assess and compare the effectiveness and beneﬁt
of various bypass materials in leg bypass surgery from a medical
and economic perspective. METHODS: A systematic review of
the literature was performed using established electronic data
bases including Medline, Embase, Cochrane Library and others
for literature from 1999–2004 in English and German. Of 4526
articles originally retrieved, 630 where examined in detail.
RESULTS: The systematic review of literature resulted in two
systematic reviews and eleven randomized trials comparing the
medical effects of different bypass materials in leg bypass surgery.
Primary patency (deﬁned as the presence of a patent graft
without any additional intervention) is the main outcome
measure from a medical perspective. From an economic per-
spective different bypass materials are evaluated insufﬁciently.
Therefore a model has been developed to determine cost-
effectiveness of different bypass materials including the cost of
the prosthetic material and operation time. For long-term results
complication rates have to be considered as well. CONCLU-
SIONS: From a medical perspective autologous material is the
superior choice compared to prosthetic materials in leg bypass
surgery. According to the developed model the cost-effectiveness
of different bypass materials depends on the costs and structure
of the hospital. The experience of the surgeon is an important
factor.
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OBJECTIVES: Technological advances have enabled percuta-
neous coronary intervention (PCI) to be applied to expanding
indications. However, escalating costs are of concern to patients,
providers and payers. This study assessed the incremental
medical costs of treating major in-hospital procedural complica-
tions incurred by patients undergoing PCI. METHODS: We con-
